Nortriptyline Rivopharm Uk (Nortriptyline)

Nortriptyline is indicated for several conditions within the depressive and pain management pathways.

• Major depressive disorder: alleviates depressive symptoms and improves mood in adult patients.
• Neuropathic pain: reduces pain intensity associated with peripheral nerve injury.
• Migraine prophylaxis: decreases frequency and severity of migraine attacks when used as preventive therapy.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin, increasing their synaptic concentrations. It also antagonizes muscarinic acetylcholine, histamine H1, and alpha‑adrenergic receptors, contributing to its therapeutic and side‑effect profile. These actions collectively modulate mood, pain perception, and vascular tone.

Common Side Effects

• Dry mouth: reduced salivation leading to throat discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness: increased sedation, especially at treatment initiation.
• Weight gain: modest increase in appetite and body weight.
• Blurred vision: transient visual disturbances.
• Urinary retention: difficulty initiating urination.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, particularly in patients with pre‑existing heart disease.
• Seizures: heightened risk in susceptible individuals.
• Severe hypotension: sudden drop in blood pressure causing dizziness.
• Agranulocytosis: marked reduction in white blood cells.
• Suicidal thoughts: emergence or worsening of suicidal ideation.
• Hepatic toxicity: abnormal liver function tests or hepatitis.

Before initiating therapy, clinicians should consider several safety factors.

• Cardiac assessment: evaluate history of heart disease or conduction abnormalities.
• Blood pressure monitoring: watch for orthostatic hypotension, especially during dose titration.
• Gradual discontinuation: taper the dose to avoid withdrawal symptoms.
• Elderly caution: start at lower doses due to increased sensitivity to anticholinergic effects.
• Recent myocardial infarction: avoid use until cardiac stability is confirmed.
• Store at room temperature: keep in the original pack, protect from moisture.

Nortriptyline may interact with a range of medicines, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: increased serotonin toxicity.
• Other tricyclic antidepressants: additive cardiotoxic effects.
• Antiarrhythmic drugs (e.g., quinidine): heightened risk of arrhythmias.
• Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nortriptyline plasma levels.

Moderate Interactions (Monitor Closely)

• Antihistamines: enhanced anticholinergic burden.
• CNS depressants (e.g., benzodiazepines, alcohol): increased sedation.
• Anticholinergic agents: potentiation of dry mouth and constipation.
• NSAIDs: possible increase in bleeding risk.
• Diuretics: may exacerbate orthostatic hypotension.